1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Defense Health Agency (DHA) Small Business Innovation Research (SBIR) program is sponsored by Defense Health Agency (DHA), Department of Defense (DoD). The DHA SBIR program funds biomedical and health-focused technologies that enhance medical readiness, clinical care delivery, force health protection, operational medicine, and military healthcare modernization.
This includes areas like trauma care, telemedicine, diagnostics, wearable monitoring tools, and AI-enabled triage.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
DHA SBIR | Defense Health Agency Medical Innovation Funding Defense Health Agency (DHA) SBIR: Advancing Military Medicine, Operational Readiness, and Force Health Protection The Defense Health Agency (DHA) Small Business Innovation Research (SBIR) program funds biomedical and health-focused technologies that enhance medical readiness, clinical care delivery, force health protection, operational medicine, and military healthcare modernization .
DHA SBIR topics are tightly aligned with real-world needs across trauma care, battlefield triage, far-forward telemedicine, infectious-disease diagnostics, wearable monitoring tools, physiological analytics, prosthetics, rehabilitation platforms, and US-based military hospital modernization .
Because warfighter medical care must be rugged, fast, secure, interoperable, and clinically valid , DHA SBIR proposals must demonstrate both technical innovation and real clinical relevance.
Priority research domains include traumatic injury stabilization, hemorrhage control, wound-care analytics, portable medical devices, physiological monitoring, rapid point-of-care diagnostics, digital health systems, AI-enabled triage, infection surveillance, behavioral health, medical logistics , pharmaceutical stability, biomanufacturing, patient movement optimization, and field-deployable rehabilitation .
DHA strongly favors integrated clinical pathways, interoperable platforms, remote-care augmentation, and medical systems capable of deployment in austere environments , including shipboard, aviation, expeditionary, or humanitarian settings.
Phase I DHA SBIR awards typically range from $150,000 to $225,000 and support early feasibility studies, pilot designs, early assay validation, physiology-based modeling, or preliminary field-care algorithms.
Phase II awards—often between $1,000,000 and $1,600,000—support clinical prototyping, medical device refinement, usability and human-factor testing, FDA pathway planning, modeling for regulatory approval, field demonstrations, and assessments with Service medical units or military treatment facilities .
DHA is unique among DoD SBIR components because medical regulatory strategy can be central to evaluation competitiveness , particularly for technologies entering FDA Class I, II, or III pathways. Eligibility mirrors standard SBIR requirements: U.S.-owned for-profit small businesses under 500 employees , the PI must be primarily employed by the small business , and at least 50% of research effort must be executed by the small business .
Universities, medical schools, teaching hospitals, clinical research organizations, and federally funded laboratories may collaborate as subcontractors for assay development, tissue modeling, BSL laboratory work, UX evaluation, or clinical study development .
Projects involving human subjects, diagnostic handling, pharmaceuticals, implanted devices, biospecimens, animal studies, or clinical simulation must meet strict DoD IRB, HIPAA, biosafety, and FDA regulatory requirements , including appropriate ethics approvals and controlled documentation.
Competitive DHA SBIR proposals demonstrate: • clear clinical or operational relevance to military environments • manufacturability and ruggedization under austere conditions • alignment with triage workflows, telemedicine architectures, or medical logistics • a credible regulatory roadmap with FDA or device-exemption clarity • strong transition potential for Service medical units or field hospitals • dual-use commercialization in civilian trauma centers, EMS, VA health systems, biotech markets, or telehealth environments DHA Research & SBIR: https://www.
health. mil DoD SBIR Portal: https://www. dodsbirsttr.
mil ScienceDocs assists DHA SBIR and medical technology applicants with clinical proposal development, regulatory and FDA planning, usability and field-study design, medical narrative writing, milestone structuring, commercialization strategy, and technical editing. If your company plans to pursue a DHA SBIR submission or requires proposal development support, please begin the conversation at: https://www. sciencedocs.
com/quotes Find grants, services, and resources across our site.
According to the current listing, eligibility includes: U.S.-owned for-profit small businesses under 500 employees. The Principal Investigator must be primarily employed by the small business. Research institutions can collaborate as subcontractors. Confirm the full requirements in the official notice before applying.
The current listing shows phase I: typically $150,000 to $225,000; Phase II: often $1,000,000 to $1,600,000. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Defense Health Agency (DHA) Small Business Innovation Research (SBIR) program is funded by Defense Health Agency (DHA), Department of Defense (DoD). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
CDMRP's FY26 portfolio funds 34 programs, and October 2026 is dense with full-application deadlines: PRCRP October 5, PCRP October 7, MRP October 14. Every one of them is gated behind a pre-application that closed months earlier. Here is what that two-step structure actually costs applicants, and how to be inside the gate for FY27.
Read articleThe Department's FY26 SBIR/STTR Release 3 opened June 24 with roughly 37 topics across DARPA, the Navy, the Air Force, and the defense components, all closing July 22. The compressed four-week window is unforgiving, but the bigger mistake founders make is treating every component the same. Here is how to read the release, the eligibility rules that disqualify good companies, and why the component you target matters more than the topic you pick.
Read articleDoW's 2026 SBIR Broad Agency Announcement now operates on a monthly pre-release / quarterly close cadence. The 42 topics closing June 24 are the first test of whether the new rhythm produces the steady-state deal flow defense innovators have been asking for since 2022.
Read article